Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


failure rate
Jul 30, 2009

when you talk about a failure rate of HIV Meds of 5 percent a year. Does that include those who are not adherent or just patients who faithfully take meds. Also, I'm not good at math but does that mean each year an individual runs the risk of 5 percent failure which would accumulate to someting like 25 percent after five and 50 percent after 10 years?

Response from Dr. Henry

That general failure rate refers to a population of patients with mixed levels of adherence as well as to the given first drug regimen. Patients who fail a given initial therapy in western countries can often achieve re-suppression with a properly chosed follow-up regimen so that the very long term odds (>> decades ) of maintaining good viral suppression appears good overall. KH



Previous
zeffix
Next
Gastritis and efivarenz

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement